Stocksigma LogoStocksigma Logo

GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend

GPT Healthcare Limited has scheduled its Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results alongside the

GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend

GPT Healthcare Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend GPT Healthcare Limited has scheduled its Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results alongside the statutory auditors' limited review report for Q2 and H1 ended 30th Sep'26. The board will also evaluate the declaration of an interim dividend for FY 2026-27 on the company's equity share capital. Consequently, the trading window for company securities remains closed until 7th Nov'26 in compliance with insider trading regulations.

Original exchange filing (PDF)

More announcements from GPT Healthcare Ltd

All GPT Healthcare Ltd announcements